# Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP

> **NCT04929548** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Wuhan University** · enrollment: 20 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Pyrotinib Maleate Tablets

## Key facts

- **NCT ID:** NCT04929548
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-01-05
- **Primary completion:** 2022-01-05
- **Final completion:** 2027-09-20
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929548, "Exploratory Study of Neoadjuvant Treatment of HER2-positive Breast Cancer With Py in Combination With HP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04929548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*